Healthcare · Industry

Biotechnology - List & Prices (608 stocks)

By market cap Page 6 of 13 Prices: Oct 21, 2026 close Last Updated: Oct 21, 2026

Biotechnology - List & Prices
#	Company	Ticker	Price	Mkt cap	P/E	Div yield
251	Opus Genetics, Inc.	IRD	$4.12	$342.35M	unprofitable	—
252	Galectin Therapeutics Inc.	GALT	$3.37	$339.86M	unprofitable	—
253	Enanta Pharmaceuticals, Inc.	ENTA	$11.31	$329.41M	unprofitable	—
254	Atea Pharmaceuticals, Inc.	AVIR	$4.08	$327.24M	unprofitable	—
255	C4 Therapeutics, Inc.	CCCC	$3.17	$321.10M	unprofitable	—
256	Artiva Biotherapeutics, Inc.	ARTV	$6.49	$317.30M	unprofitable	—
257	Arcturus Therapeutics Holdings Inc.	ARCT	$11.07	$314.64M	unprofitable	—
258	Contineum Therapeutics, Inc.	CTNM	$8.35	$314.14M	unprofitable	—
259	Turn Therapeutics Inc.	TTRX	$10.15	$308.23M	unprofitable	—
260	Vogenx, Inc.	VOGX	$20.39	$302.90M	unprofitable	—
261	X4 Pharmaceuticals, Inc.	XFOR	$3.01	$298.43M	—	—
262	Surrozen, Inc.	SRZN	$25.32	$297.60M	unprofitable	—
263	Benitec Biopharma Inc.	BNTC	$8.50	$295.11M	unprofitable	—
264	Century Therapeutics, Inc.	IPSC	$1.61	$291.53M	unprofitable	—
265	Prelude Therapeutics Incorporated	PRLD	$3.65	$291.28M	unprofitable	—
266	Agenus Inc.	AGEN	$6.40	$289.04M	2.5	—
267	Cabaletta Bio, Inc.	CABA	$1.54	$286.53M	unprofitable	—
268	Fulcrum Therapeutics, Inc.	FULC	$3.70	$282.61M	unprofitable	—
269	Ocugen, Inc.	OCGN	$0.82	$276.41M	unprofitable	—
270	Vicore Pharma Holding AB (publ)	VCRE	$9.28	$261.37M	unprofitable	—
271	Clinuvel Pharmaceuticals Limited	CUVL	$5.12	$258.49M	11.4	0.69%
272	Q32 Bio Inc.	QTTB	$8.67	$258.10M	2.8	—
273	Abeona Therapeutics Inc.	ABEO	$4.51	$257.90M	unprofitable	—
274	SAB Biotherapeutics, Inc.	SABS	$2.82	$256.58M	unprofitable	—
275	Bicycle Therapeutics plc	BCYC	$3.57	$251.97M	unprofitable	—
276	Larimar Therapeutics, Inc.	LRMR	$2.42	$251.40M	unprofitable	—
277	Fate Therapeutics, Inc.	FATE	$2.07	$248.03M	unprofitable	—
278	Lexeo Therapeutics, Inc.	LXEO	$3.00	$246.26M	unprofitable	—
279	AC Immune SA	ACIU	$2.47	$245.58M	unprofitable	—
280	Palisade Bio, Inc.	PALI	$1.40	$243.98M	—	—
281	Greenwich LifeSciences, Inc.	GLSI	$16.57	$243.22M	unprofitable	—
282	Vanda Pharmaceuticals Inc.	VNDA	$4.01	$242.46M	unprofitable	—
283	Immuneering Corporation	IMRX	$3.74	$241.97M	unprofitable	—
284	Rocket Pharmaceuticals, Inc.	RCKT	$2.20	$241.50M	unprofitable	—
285	Lineage Cell Therapeutics, Inc.	LCTX	$0.95	$240.64M	unprofitable	—
286	Inhibikase Therapeutics, Inc.	IKT	$1.66	$231.63M	unprofitable	—
287	Zentalis Pharmaceuticals, Inc.	ZNTL	$2.36	$231.57M	unprofitable	—
288	Lyell Immunopharma, Inc.	LYEL	$9.41	$230.59M	unprofitable	—
289	MacroGenics, Inc.	MGNX	$3.59	$228.68M	unprofitable	—
290	InflaRx N.V. Common Stock	IFRX	$1.55	$228.42M	unprofitable	—
291	BridgeBio Oncology Therapeutics, Inc.	BBOT	$2.68	$226.09M	unprofitable	—
292	Keros Therapeutics, Inc.	KROS	$11.18	$221.67M	unprofitable	—
293	CAMP4 THERAPEUTICS CORPORATION	CAMP	$3.29	$215.24M	unprofitable	—
294	Sol-Gel Technologies Ltd.	SLGL	$65.72	$215.17M	unprofitable	—
295	Pyxis Oncology, Inc.	PYXS	$1.76	$210.24M	unprofitable	—
296	Alector, Inc.	ALEC	$1.87	$208.80M	unprofitable	—
297	Protalix BioTherapeutics, Inc.	PLX	$2.57	$207.07M	11.2	—
298	Satellos Bioscience Inc.	MSCL.TO	CA$9.52	CA$201.98M	unprofitable	—
299	Cartesian Therapeutics, Inc.	RNAC	$6.42	$194.24M	unprofitable	—
300	ProQR Therapeutics N.V.	PRQR	$1.37	$193.33M	unprofitable	—

IRD

Opus Genetics, Inc.

$4.12

Healthcare / Biotechnology

Market Cap: $342.35M
P/E: unprofitable

GALT

Galectin Therapeutics Inc.

$3.37

Healthcare / Biotechnology

Market Cap: $339.86M
P/E: unprofitable

ENTA

Enanta Pharmaceuticals, Inc.

$11.31

Healthcare / Biotechnology

Market Cap: $329.41M
P/E: unprofitable

AVIR

Atea Pharmaceuticals, Inc.

$4.08

Healthcare / Biotechnology

Market Cap: $327.24M
P/E: unprofitable

CCCC

C4 Therapeutics, Inc.

$3.17

Healthcare / Biotechnology

Market Cap: $321.10M
P/E: unprofitable

ARTV

Artiva Biotherapeutics, Inc.

$6.49

Healthcare / Biotechnology

Market Cap: $317.30M
P/E: unprofitable

ARCT

Arcturus Therapeutics Holdings Inc.

$11.07

Healthcare / Biotechnology

Market Cap: $314.64M
P/E: unprofitable

CTNM

Contineum Therapeutics, Inc.

$8.35

Healthcare / Biotechnology

Market Cap: $314.14M
P/E: unprofitable

TTRX

Turn Therapeutics Inc.

$10.15

Healthcare / Biotechnology

Market Cap: $308.23M
P/E: unprofitable

VOGX

Vogenx, Inc.

$20.39

Healthcare / Biotechnology

Market Cap: $302.90M
P/E: unprofitable

XFOR

X4 Pharmaceuticals, Inc.

$3.01

Healthcare / Biotechnology

Market Cap: $298.43M

SRZN

Surrozen, Inc.

$25.32

Healthcare / Biotechnology

Market Cap: $297.60M
P/E: unprofitable

BNTC

Benitec Biopharma Inc.

$8.50

Healthcare / Biotechnology

Market Cap: $295.11M
P/E: unprofitable

IPSC

Century Therapeutics, Inc.

$1.61

Healthcare / Biotechnology

Market Cap: $291.53M
P/E: unprofitable

PRLD

Prelude Therapeutics Incorporated

$3.65

Healthcare / Biotechnology

Market Cap: $291.28M
P/E: unprofitable

AGEN

Agenus Inc.

$6.40

Healthcare / Biotechnology

Market Cap: $289.04M
P/E: 2.5

CABA

Cabaletta Bio, Inc.

$1.54

Healthcare / Biotechnology

Market Cap: $286.53M
P/E: unprofitable

FULC

Fulcrum Therapeutics, Inc.

$3.70

Healthcare / Biotechnology

Market Cap: $282.61M
P/E: unprofitable

OCGN

Ocugen, Inc.

$0.82

Healthcare / Biotechnology

Market Cap: $276.41M
P/E: unprofitable

VCRE

Vicore Pharma Holding AB (publ)

$9.28

Healthcare / Biotechnology

Market Cap: $261.37M
P/E: unprofitable

CUVL

Clinuvel Pharmaceuticals Limited

$5.12

Healthcare / Biotechnology

Market Cap: $258.49M
P/E: 11.4
Dividend Yield: 0.69%

QTTB

Q32 Bio Inc.

$8.67

Healthcare / Biotechnology

Market Cap: $258.10M
P/E: 2.8

ABEO

Abeona Therapeutics Inc.

$4.51

Healthcare / Biotechnology

Market Cap: $257.90M
P/E: unprofitable

SABS

SAB Biotherapeutics, Inc.

$2.82

Healthcare / Biotechnology

Market Cap: $256.58M
P/E: unprofitable

BCYC

Bicycle Therapeutics plc

$3.57

Healthcare / Biotechnology

Market Cap: $251.97M
P/E: unprofitable

LRMR

Larimar Therapeutics, Inc.

$2.42

Healthcare / Biotechnology

Market Cap: $251.40M
P/E: unprofitable

FATE

Fate Therapeutics, Inc.

$2.07

Healthcare / Biotechnology

Market Cap: $248.03M
P/E: unprofitable

LXEO

Lexeo Therapeutics, Inc.

$3.00

Healthcare / Biotechnology

Market Cap: $246.26M
P/E: unprofitable

ACIU

AC Immune SA

$2.47

Healthcare / Biotechnology

Market Cap: $245.58M
P/E: unprofitable

PALI

Palisade Bio, Inc.

$1.40

Healthcare / Biotechnology

Market Cap: $243.98M

GLSI

Greenwich LifeSciences, Inc.

$16.57

Healthcare / Biotechnology

Market Cap: $243.22M
P/E: unprofitable

VNDA

Vanda Pharmaceuticals Inc.

$4.01

Healthcare / Biotechnology

Market Cap: $242.46M
P/E: unprofitable

IMRX

Immuneering Corporation

$3.74

Healthcare / Biotechnology

Market Cap: $241.97M
P/E: unprofitable

RCKT

Rocket Pharmaceuticals, Inc.

$2.20

Healthcare / Biotechnology

Market Cap: $241.50M
P/E: unprofitable

LCTX

Lineage Cell Therapeutics, Inc.

$0.95

Healthcare / Biotechnology

Market Cap: $240.64M
P/E: unprofitable

IKT

Inhibikase Therapeutics, Inc.

$1.66

Healthcare / Biotechnology

Market Cap: $231.63M
P/E: unprofitable

ZNTL

Zentalis Pharmaceuticals, Inc.

$2.36

Healthcare / Biotechnology

Market Cap: $231.57M
P/E: unprofitable

LYEL

Lyell Immunopharma, Inc.

$9.41

Healthcare / Biotechnology

Market Cap: $230.59M
P/E: unprofitable

MGNX

MacroGenics, Inc.

$3.59

Healthcare / Biotechnology

Market Cap: $228.68M
P/E: unprofitable

IFRX

InflaRx N.V. Common Stock

$1.55

Healthcare / Biotechnology

Market Cap: $228.42M
P/E: unprofitable

BBOT

BridgeBio Oncology Therapeutics, Inc.

$2.68

Healthcare / Biotechnology

Market Cap: $226.09M
P/E: unprofitable

KROS

Keros Therapeutics, Inc.

$11.18

Healthcare / Biotechnology

Market Cap: $221.67M
P/E: unprofitable

CAMP

CAMP4 THERAPEUTICS CORPORATION

$3.29

Healthcare / Biotechnology

Market Cap: $215.24M
P/E: unprofitable

SLGL

Sol-Gel Technologies Ltd.

$65.72

Healthcare / Biotechnology

Market Cap: $215.17M
P/E: unprofitable

PYXS

Pyxis Oncology, Inc.

$1.76

Healthcare / Biotechnology

Market Cap: $210.24M
P/E: unprofitable

ALEC

Alector, Inc.

$1.87

Healthcare / Biotechnology

Market Cap: $208.80M
P/E: unprofitable

PLX

Protalix BioTherapeutics, Inc.

$2.57

Healthcare / Biotechnology

Market Cap: $207.07M
P/E: 11.2

MSCL.TO

Satellos Bioscience Inc.

CA$9.52

Healthcare / Biotechnology

Market Cap: CA$201.98M
P/E: unprofitable

RNAC

Cartesian Therapeutics, Inc.

$6.42

Healthcare / Biotechnology

Market Cap: $194.24M
P/E: unprofitable

PRQR

ProQR Therapeutics N.V.

$1.37

Healthcare / Biotechnology

Market Cap: $193.33M
P/E: unprofitable

Showing 251–300 of 608 · ranked by market capitalization

Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.